REFERENCES
- Atkinson, A. B., Brown, J. J., Lever, A. F. & Robertson, J. I. S. 1980. Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet, ii, 105.
- Atlas, S. A., Case, B. B., Sealey, J. E., Laragh, G. H. & McKinstry, D. N. 1979. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natriuresis. Hypertension 1, 274.
- Aurell, M., Delin, K., Herlitz, H. & Mulec, H. Captopril treatment in hypertensive dialysis patients. To be published.
- Aurell, M., Rudin, A., Tisell, L. E., Kindblom, L. E., Derkx, F. & Schalekamp, M. 1981. Captopril effect in a case with renin producing non-renal tumour. In Secondary forms of hypertension. Current diagnosis and management (ed. Blaufox & Bianchi), pp. 179–186. Grüne & Stratton, New York.
- Brunner, H. R., Gavras, H., Waeber, B., Kershaw, G. R., Turini, G. A., Wukovich, R. A., McKinstry, D. N. & Gavras, I. 1979. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Int Med 90, 19.
- Bröchner-Mortensen, J. 1972. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30, 271.
- Dengler, H. 1956. Über einen reninartigen Wirkstoff in Arterienextrakten. Arch Exp Path Pharmacol 227, 481.
- Düsterdiek, G. & McElwee, G. 1971. Estimation of angiotensin II ocncentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest 2, 32.
- Ferguson, R. K., Vlasses, P. H., Koplin, R. J., Shirinian, A., Burke, J. F. & Alexander, J. C. 1980. Captopril in severe treatment-resistant hypertension. Am Heart J 99, 579.
- Giese, J., Jörgensen, M., Nielsen, M. D., Lund, J. O. & Munck, O. 1970. Plasma renin concentration measured by use of radioimmunoassay for angiotensin I. Scand J Clin Lab Invest 26, 355.
- Gould, A. B., Skeggs, L. T. & Kahn, J. R. 1964. The presence of renin activity in blood vessel walls. J Exp Med 119, 389.
- Heel, R. C., Brogden, R. N., Speight, T. M. & Avery, G. S. 1980. Captopril: A preliminary review of its pharmacological properties and therapeutical efficacy. Drugs 20, 409.
- Kappelgaard, A. M., Nielsen, M. D. & Giese, J. 1976. Measurement of angiotensin II in human plasma: Technical modifications and practical experience. Clin Chim Acta 67, 299.
- McCaa, R. E., Hall, J. E. & McCaa, C. S. 1978. The effects of angiotensin I converting enzyme inhibition on arterial blood pressure and urinary excretion: Role of the renal renin-angiotensin and Kallikrein-kinin system. Circ Res (Suppl. 1) 43: 32.
- Ondetti, M. A., Rubin, B. & Cushman, D. W. 1977. Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents. Science 196, 441.
- Prins, E. J. L., Hoorntje, S. J., Weening, J. J. & Donker, A. J. M. 1979. Nephrotic syndrome in patient on captopril. Lancet, ii, 306.
- Rubin, B. & Antonaccio, M. J. 1980. Captopril: In Pharmacology of antihypertensive drugs (ed. A.Serrabine), pp. 21–42. Raven Press, New York.
- Studer, A., Lüscher, T., Siegenthaler, W. & Vetter, W. 1981. Captopril in various forms of severe therapy-resistant hypertension. Klin Wochenschr 59, 59.
- Swartz, S. L., Williams, G. H., Hollenberg, N. K., Levine, L., Dluhy, R. G. & Moore, T. J. 1980. Captopril induced changes in prostaglandin production. J Clin Invest 65, 1257.
- White, N. J., Rajagopalan, B., Yahaya, H. & Ledingham, J. G. G. 1980. Captopril and furosemide in severe drug-resistant hypertension. Lancet, ii, 108.